Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing
LITTLETON, Colo., Oct. 5, 2023 /PRNewswire/ -- Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics (NYSE: DGX) that aims to accelerate dialysis laboratory testing and reduce the laboratory costs of dialysis programs for patients with end-stage renal disease (ESRD).
- LITTLETON, Colo., Oct. 5, 2023 /PRNewswire/ -- Neway, LLC, the U.S. leader in value-based dialysis lab care, today announced a strategic lab services arrangement with Quest Diagnostics (NYSE: DGX) that aims to accelerate dialysis laboratory testing and reduce the laboratory costs of dialysis programs for patients with end-stage renal disease (ESRD).
- Under the terms of the agreement, Neway will utilize the extensive lab network of Quest Diagnostics to provide local dialysis laboratory testing services with typically next-day results after arrival at a Quest Diagnostics laboratory.
- By utilizing Quest's distributed lab network, Neway and its affiliated dialysis centers and their patients will experience faster testing and results reporting and lower transportation costs.
- "Working together with Neway, we will address these challenges and expedite test results while maintaining the highest level of quality for patients with ESRD."